We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

195 hedge funds and large institutions have $840M invested in BioTelemetry, Inc. in 2017 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 70 increasing their positions, 68 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 20

30% more call options, than puts

Call options by funds: $9.89M | Put options by funds: $7.62M

27% more capital invested

Capital invested by funds: $661M → $840M (+$179M)

10% more funds holding

Funds holding: 178195 (+17)

3% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 68

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

Holders
195
Holders Change
+17
Holders Change %
+9.55%
% of All Funds
4.86%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
38
Increased
70
Reduced
68
Closed
20
Calls
$9.89M
Puts
$7.62M
Net Calls
+$2.27M
Net Calls Change
+$902K

BEAT Hedge Fund Activity: Q2 2017 in Review

195 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q2 2017, worth a combined $840M — up 27% from $661M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new BEAT positions and 20 closed out — a net gain of 18 holders — while 70 added to existing stakes and 68 trimmed.

The largest buyer was Hood River Capital Management, opening a new position worth an estimated $23.8M. The largest seller was Acadian Asset Management, cutting an estimated $7.58M.

  • 195 institutional investors held BioTelemetry, Inc. (BEAT) as of Q2 2017, up from 178 in Q1 2017.
  • Funds reported $840M of BioTelemetry, Inc. stock for Q2 2017, up 27% quarter-over-quarter.
  • 38 funds opened new BioTelemetry, Inc. positions in Q2 2017 and 20 closed out, a net change of +18 holders.
  • The largest BioTelemetry, Inc. buyer in Q2 2017 was Hood River Capital Management, an estimated $23.8M added.
  • The largest BioTelemetry, Inc. seller in Q2 2017 was Acadian Asset Management, an estimated $7.58M sold.

Based on aggregated 13F filings for Q2 2017.